An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

NCT06721598 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

60

Enrollment

NETWORK

Sponsor class

Conditions

Non-Hodgkin Lymphoma, B-cell
Acute Lymphoblastic Leukemia ALL

Sponsor

National Research Center for Hematology, Russia